0001372514-23-000033.txt : 20230307
0001372514-23-000033.hdr.sgml : 20230307
20230307201436
ACCESSION NUMBER: 0001372514-23-000033
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230303
FILED AS OF DATE: 20230307
DATE AS OF CHANGE: 20230307
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gayron Kenneth L
CENTRAL INDEX KEY: 0001669103
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36672
FILM NUMBER: 23714565
MAIL ADDRESS:
STREET 1: 75 NETWORK DRIVE
CITY: BURLINGTON
STATE: MA
ZIP: 34212
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KIORA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001372514
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 332 ENCINITAS BOULEVARD
STREET 2: SUITE 102
CITY: ENCINITAS
STATE: CA
ZIP: 92024
BUSINESS PHONE: 781-788-8869
MAIL ADDRESS:
STREET 1: 332 ENCINITAS BOULEVARD
STREET 2: SUITE 102
CITY: ENCINITAS
STATE: CA
ZIP: 92024
FORMER COMPANY:
FORMER CONFORMED NAME: EYEGATE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060811
4
1
wf-form4_167823806525564.xml
FORM 4
X0306
4
2023-03-03
0
0001372514
KIORA PHARMACEUTICALS INC
KPRX
0001669103
Gayron Kenneth L
332 ENCINITAS BLVD., SUITE 102
ENCINITAS
CA
92024
1
0
0
0
Stock Option (right to buy)
3.83
2023-03-03
4
A
0
8000
0
A
2033-03-03
Common Stock
8000.0
8000
D
The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on March 3, 2024.
/s/ Robert A. Petitt, Attorney-in-Fact
2023-03-08